Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Sinai Health System | OTHER |
| University Health Network, Toronto | OTHER |
Not provided
Not provided
Not provided
Not provided
To investigate the safety and efficacy of a novel atrial flow regulator (AFR) device in patients with heart failure and preserved ejection fraction.
The study will allow us to demonstrate the safety of the AFR device as well as determine the clinical response of the therapeutic intervention. In addition, the invasive exercise hemodynamics will provide objective data for the changes in the cardiac hemodynamics and delineate underlying mechanisms of creating a permanent inter atrial shunting.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Control arm | Sham Comparator | Sham procedure to include cardiac catheterization and hemodynamic. Ongoing management at the discretion of the treating physician. Patient to undergo |
|
| AFR arm | Experimental | Implantation of Occlutech atrial flow regulator (AFR) device |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| AFR implantation | Device | Implantation of atrial flow regulator (AFR) device |
| |
| Measure | Description | Time Frame |
|---|---|---|
| 6MWT | Six minute walk test at 12 months | 12 months |
| Measure | Description | Time Frame |
|---|---|---|
| MACE | Composite of cardiac death, heart failure hospitalization and worsening heart failure | 12 months |
| Cardiac death | Death from a cardiac cause (myocardial infarction, sudden death) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Asim Cheema, MD, PhD | Contact | 416-864-5739 | cheemaa@smh.ca |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| St. Michael's hospital | Toronto | Ontario | M5B 1W8 | Canada |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Multicenter, randomized, sham controlled, single blind with objective end points.
Not provided
Not provided
Not provided
| Sham procedure |
| Device |
Sham procedure to include cardiac catheterization and hemodynamic. Ongoing management at the discretion of the treating physician. Patient to undergo |
|
| 12 months |
| Congestive heart failure (CHF) | Heart failure hospitalization, worsening heart failure | 12 months |
| Quality of Life (QOL) | QOL as per KCCQE questionaire | 12 months |
| Sinai Health System | Toronto | Ontario | Canada |
|
| University Health Network | Toronto | Ontario | Canada |
|